<!DOCTYPE html>
<html>
    <head>
        <title>Processa Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)</title>
        <link href="https://ir.stockpr.com/processapharmaceuticals/stylesheets/ir.stockpr.css" rel="stylesheet" type="text/css">
        <script type="text/javascript" src="https://ir.stockpr.com/javascripts/ir.js"></script>
        <link rel="stylesheet" type="text/css" href="https://ir.stockpr.com/stylesheets/xbrl.css">
        <script type="text/javascript" src="https://d1io3yog0oux5.cloudfront.net/_a67d450d2acc59dd775509682ce34f1e/processapharmaceuticals/files/theme/js/aside/ir/_js/all.js"></script>
    </head>
    <body>
        <div class="xbrl-content">
            <h3>Quarterly report pursuant to Section 13 or 15(d)</h3>
            <div id="xbrl-menu-top">
                <div class="navigation">
                    <ul class="xbrl-sf-menu">
                        
                            <li>
                                <a class="menu-item " href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/39">Cover</a>
                                <ul class="submenu">
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/39">Document and Entity Information</a></li>
                                                                    </ul>
                            </li>
                                                    <li>
                                <a class="menu-item " href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/40">Financial Statements</a>
                                <ul class="submenu">
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/40">BALANCE SHEETS (unaudited)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/41">BALANCE SHEETS (Parenthetical)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/42">STATEMENTS OF OPERATIONS (unaudited)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/43">STATEMENT OF CASH FLOWS (unaudited)</a></li>
                                                                    </ul>
                            </li>
                                                    <li>
                                <a class="menu-item " href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/44">Notes to Financial Statements</a>
                                <ul class="submenu">
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/44">Principal Business Activities</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/45">Basis of Presenation and Summary of Significant Accounting Policies</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/46">Property and Equipment</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/47">Acquistion</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/48">Notes Payable</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/49">Stockholders&#039; Equity Note</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/50">Net Loss Per Common Share</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/51">Commitments and Contingencies Note</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/52">Related Party Transactions</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/53">Supplemental Cash Flow Information</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/54">Subsequent Events</a></li>
                                                                    </ul>
                            </li>
                                                    <li>
                                <a class="menu-item " href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/55">Accounting Policies</a>
                                <ul class="submenu">
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/55">Basis of Presenation and Summary of Significant Accounting Policies: Basis of Presentation (Policies)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/56">Basis of Presenation and Summary of Significant Accounting Policies: Recent Accounting Pronouncements (Policies)</a></li>
                                                                    </ul>
                            </li>
                                                    <li>
                                <a class="menu-item current" href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/57">Notes Tables</a>
                                <ul class="submenu">
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/57">Property and Equipment: Summary of the cost of property and equipment (Tables)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/58">Notes Payable: Schedule of principal payments, senior subordinated note payable (Tables)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/59">Notes Payable: Mandatory principal payments, loan payable (Tables)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/60">Stockholders&#039; Equity Note: Schedule of Stock Option Activity (Tables)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/61">Stockholders&#039; Equity Note: Schedule of Stock Option Valuation Assumptions (Tables)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/62">Stockholders&#039; Equity Note: Schedule of Performance Stock Option Activity (Tables)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/63">Net Loss Per Common Share: Schedule of Earnings Per Share, Basic and Diluted (Tables)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/64">Supplemental Cash Flow Information: Schedule of Cash Flow, Supplemental Disclosures (Tables)</a></li>
                                                                    </ul>
                            </li>
                                                    <li>
                                <a class="menu-item " href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/65">Notes Details</a>
                                <ul class="submenu">
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/65">Basis of Presenation and Summary of Significant Accounting Policies: Basis of Presentation (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/66">Property and Equipment: Summary of the cost of property and equipment (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/67">Property and Equipment (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/68">Acquistion (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/69">Notes Payable (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/70">Notes Payable: Schedule of principal payments, senior subordinated note payable (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/71">Notes Payable: Mandatory principal payments, loan payable (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/72">Stockholders&#039; Equity Note (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/73">Stockholders&#039; Equity Note: Schedule of Stock Option Activity (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/74">Stockholders&#039; Equity Note: Schedule of Performance Stock Option Activity (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/75">Net Loss Per Common Share: Schedule of Earnings Per Share, Basic and Diluted (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/76">Commitments and Contingencies Note (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/77">Related Party Transactions (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/78">Supplemental Cash Flow Information: Schedule of Cash Flow, Supplemental Disclosures (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/79">Subsequent Events (Details)</a></li>
                                                                    </ul>
                            </li>
                                            </ul>
                </div>
            </div>
            <div class="spr-xbrl-document">
                <h4>Stockholders&#039; Equity Note: Schedule of Performance Stock Option Activity (Tables)</h4>
                                <div style="clear:both;"></div>
            </div>
        </div>
    </body>
</html>